Prevention is Key: A Simple Step to Better Health At the end of each year, the months of October and November are marked by two major awareness campaigns: Pink October and Movember. These initiatives aim to draw attention to breast … Read More
VERSATILE, PERSONALISED ACTIVE INTERFACES FOR MEDICAL DEVICES AND DAILY USE
Hospital-acquired infection
0
%
of cases related with medical devices
Antibiotic-resistant bacteria
0
K
deaths in Europe each year
Antibiotic resistance
0
M
deaths expected worldwide by 2050
OUR STORY
SPARTHA Medical is a spin-off from INSERM UMR1121 a public research institute with more than 20 years of experience in development of engineered coatings.
SPARTHA Medical’s core technologies are patented-based inventions coming from two European projects (IMMODGEL and PANBioRA) that started in 2013.
OUR TEAM
Our Multidisciplinary Team brings together Know-How and Expertise
| Medical Device Design and Development
| Coating Technologies
| BioTechnology Business Development
| Production and Regulatory Affairs
OUR SUPPORTS
Spartha Medical has a strong support from :
| University of Strasbourg | SATT Conectus | INSERM| Biovalley France.
We financially supported by | Grand Est region (Start-up support) | French Public Bank of Investment (BPI France, i-Lab 2019) | and European Union
OUR PAGE ON STRASBOURG’S BIOMEDECINE CENTRE, WHERE OUR LABS ARE
TAKE A LOOK AT OUR LATEST NEWS
Launch of Project KISSMat
Launch of Project KISSMat The KISSMat project was officially launched a few months ago with the objective of identifying new antimicrobial solutions for the medical, cosmetic, and food sectors. KISSMat brings together several entities from the Grand Est region, that … Read More
BIOFACE Project wins RHU for Oncology Facial Reconstruction
BIOFACE Project wins RHU for Oncology Facial Reconstruction As part of France 2030, the BIOFACE project, led by Professor Agnès Dupret-Bories in Toulouse, is the winner of the Health 2023 call for projects for university hospital research (RHU). BIOFACE has … Read More
Disclaimer: Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Directorate-General for Communications Networks, Content and Technology. Neither the European Union nor the granting authority can be held responsible for them.